Immunic, Inc. (IMUX)

Market Closed

26 Oct, 08:00 PM

NASDAQ (NGS)

7. 29

-0.12

-1.6194%

After Hours

7. 80

+0.51 +6.9959%

101.11M Market Cap

- P/E Ratio

- Div Yield

17,149 Volume

-2.13 Eps

$ 7.41

Previous Close

Investors:

Analysts:

Day Range

7.08 7.69

Year Range

5.06 17.43

Want to track IMUX and more in your Portfolio? 🎯

Immunic, Inc. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
ABB Alexander Bjornager Bonde Danske Bank A/S	2	$31	$14.36	-$16.64	-53.68%
MS Matthew Sutula ALPS ADVISORS Inc.	13,824	$212,474.88	$100,638.72	-$111,836.16	-52.64%
MM Masih Mohebbi Laurion Capital Management LP	610,326	$9.38M	$4.43M	-$4.95M	-52.77%
DRO Donal Reamonn O'Sullivan Brevan Howard Capital Management LP	4,584.3	$50,885.73	$32,915.27	-$17,970.46	-35.32%
KE Kathleen Engler Baader Bank Aktiengesellschaft	1,128.1	$12,521.91	$8,206.93	-$4,314.98	-34.46%
Point72 Asset Management LP Point72 Asset Management LP	10,806	$166,088	$76,830.66	-$89,257.34	-53.74%
Li Peng China Universal Asset Management Co. Ltd.	6,400	$98,624	$46,272	-$52,352	-53.08%
KJ Ken Joseph Braidwel LLP	645,010	$9.91M	$4.63M	-$5.29M	-53.32%
Hui Fai Tam Caitong International Asset Management Co. Ltd.	2	$31	$14.34	-$16.66	-53.74%
Jim Harding Propel Bio Management LLC	325,022	$5M	$2.4M	-$2.59M	-51.89%
Gregory Bosch Strategies Wealth Advisors, LLC	10,000	$153,700	$72,650	-$81,050	-52.73%